Table: Immuno Biological Lab -Q1 group results
Aug 8 (Reuters)-
Immuno Biological Laboratories Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Jun 30, 2024 Jun 30, 2023 Mar 31, 2025
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 229 mln 177 mln 925 mln
(+29.6 pct) (+13.3 pct) (+13.3 pct)
Operating 51 mln 0 mln 120 mln
(+15.1 pct)
Recurring 56 mln 13 mln 120 mln
(+318.5 pct) (-4.3 pct)
Net 51 mln 11 mln 115 mln
(+359.9 pct) (-38.4 pct)
EPS 5.51 yen 1.19 yen 12.30 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Immuno Biological Laboratories Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4570.T